BAPINEUZUMAB (236-ALANINE,237-ALANINE,239-ALANINE) (HUMANIZED CLONE 3D6 .GAMMA.1-CHAIN)
UNII 1L4R721M8L

Substance Identification & Data

This profile provides standardized clinical and technical data for Bapineuzumab (236-alanine,237-alanine,239-alanine) (humanized Clone 3d6 .gamma.1-chain), uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1L4R721M8L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1345737-18-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1L4R721M8L

CAS Registry Number

1345737-18-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BAPINEUZUMAB (236-ALANINE,237-ALANINE,239-ALANINE) (HUMANIZED CLONE 3D6 .GAMMA.1-CHAIN)

Official standardized name for this substance within the FDA UNII nomenclature system.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bapineuzumab (236-alanine,237-alanine,239-alanine) (humanized Clone 3d6 .gamma.1-chain). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.